Development and identification of a new Vero cell-based live attenuated influenza B vaccine by a modified classical reassortment method-Reference-Cited by-同舟云学术

Development and identification of a new Vero cell-based live attenuated influenza B vaccine by a modified classical reassortment method

Published:2017-07-14 Issue:8 Volume:16 Page:855-863
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Yang Fan¹²,Ma Lei¹,Zhou Jian¹,Wu Yinjie¹,Gao Jingxia¹,Song Shaohui¹,Geng Xingliang¹,Guo Qi¹,Li Zhuofan¹,Li Weidong³,Liao Guoyang¹,Li Yufeng⁴

Affiliation:

1. The fifth Department of Biological products, Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Kunming, People’s Republic of China

2. Medical Faculty, Kunming University of Science and Technology, Kunming, People’s Republic of China

3. The Department of Production Administration, Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Kunming, People’s Republic of China

4. Department of Cardiology, Chinese PLA General Hospital, Beijing, People’s Republic of China

Funder

Medical Science and Technology Innovation Project of Chinese Academy of Medical Sciences

Innovation team in Yunnan Province

National Science and Technology Major Project

Scientific Research Projects of Health Care

National 863 Program

International Cooperation Project

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology